HIV-1 drug resistance: prevalence in Tanzania, determinants of drug resistance and impact of interventions on treatment outcomes KU Leuven
In total approximately 1,550,000 people are living with HIV (PLHIV), of those 1,126,366 (75%) are enrolled into HIV care and treatment and out of those, 1,103,016 (98%) are on antiretroviral treatment (ART). ART programs in developing countries, including Tanzania, are now advocating a test and treat strategy (National AIDS Control Programme, 2019). However, the long-term challenges of scaling up ART will include drug toxicities, treatment ...